dactinomycin has been researched along with nifedipine in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 6 (33.33) | 18.2507 |
2000's | 4 (22.22) | 29.6817 |
2010's | 7 (38.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Desnos, C; Laran, MP; Scherman, D | 1 |
Morán, J; Rivera-Gaxiola, M | 1 |
Gundersen, CB; Umbach, JA | 1 |
Kondo, S; Kubo, H; Morimura, T; Nakatsu, S; Takeuchi, J; Yin, D | 1 |
Nakata, R; Tsukamoto, I; Wakabayashi, M | 1 |
Kondo, S; Morimura, T; Takeuchi, J; Yin, D | 1 |
Crist, SA; Humphreys, S; Jacob, RJ; Joshi-Barve, SS; Muthukumar, S; Rangnekar, VM; Sells, SF; Wood, DP | 1 |
Ali, C; Lobner, D | 1 |
Centurión, D; Cobos-Puc, LE; González-Hernández, A; Maassenvandenbrink, A; Muñoz-Islas, E; Ramírez-Rosas, MB; Sánchez-López, A; Villalón, CM | 1 |
1 review(s) available for dactinomycin and nifedipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for dactinomycin and nifedipine
Article | Year |
---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cells: stimulus-biosynthesis coupling.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholinesterase; Adrenal Medulla; Animals; Biological Transport; Carbachol; Carrier Proteins; Catecholamine Plasma Membrane Transport Proteins; Catecholamines; Cattle; Cells, Cultured; Chromaffin Granules; Chromogranin A; Chromogranins; Colforsin; Cyclic AMP; Cycloheximide; Dactinomycin; Dopamine beta-Hydroxylase; Membrane Proteins; Membrane Transport Proteins; Nifedipine; Potassium; Protein Kinase C; Tetrabenazine; Time Factors; Tritium; Tyrosine 3-Monooxygenase | 1992 |
Effect of potassium and N-methyl-D-aspartate on the aspartate aminotransferase activity in cultured cerebellar granule cells.
Topics: Analysis of Variance; Animals; Aspartate Aminotransferases; Cells, Cultured; Cerebral Cortex; Cycloheximide; Dactinomycin; Dizocilpine Maleate; Dose-Response Relationship, Drug; Kinetics; Magnesium; N-Methylaspartate; Neurons; Nifedipine; Potassium; Quinoxalines; Rats; Tetrodotoxin | 1992 |
Expression of an omega-conotoxin-sensitive calcium channel in Xenopus oocytes injected with mRNA from Torpedo electric lobe.
Topics: Animals; Barium; Cadmium; Calcium; Dactinomycin; Electric Organ; Ion Channels; Microinjections; Mollusk Venoms; Myocardium; Nifedipine; Nisoldipine; omega-Conotoxin GVIA; Oocytes; Poly A; Rats; RNA; RNA, Messenger; Torpedo; Xenopus laevis | 1987 |
Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Calcium; Calcium Channels; Cell Nucleus; Cisplatin; Cycloheximide; Dactinomycin; DNA Damage; DNA, Neoplasm; Drug Resistance; Drug Synergism; Endonucleases; Female; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasm Transplantation; Nifedipine; Nucleosomes; Tumor Cells, Cultured | 1995 |
Regulation of thymidylate synthase in regenerating rat liver after partial hepatectomy.
Topics: Animals; Blotting, Northern; Cloning, Molecular; Cycloheximide; Dactinomycin; Gene Expression Regulation, Enzymologic; Hepatectomy; Kinetics; Liver; Liver Regeneration; Male; Nifedipine; Phenoxybenzamine; Propranolol; Rats; Rats, Wistar; RNA Probes; RNA, Messenger; Thymidylate Synthase; Time Factors; Trifluoperazine | 1994 |
Combination therapy with cisplatin and nifedipine inducing apoptosis in multidrug-resistant human glioblastoma cells.
Topics: Apoptosis; Calcium; Cisplatin; Cycloheximide; Dactinomycin; DNA Damage; Drug Resistance, Multiple; Drug Synergism; Endonucleases; Enzyme Activation; Glioblastoma; Humans; Nifedipine; Tumor Cells, Cultured | 1995 |
Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells.
Topics: Androgens; Animals; Apoptosis; Cell Division; Cell Line; Cycloheximide; Dactinomycin; Gene Expression Regulation; Ionomycin; Kinetics; Male; Nifedipine; Orchiectomy; Prostate; Rats; Rats, Sprague-Dawley; Receptors, Androgen | 1994 |
Mechanisms of bFGF and NT-4 potentiation of necrotic neuronal death.
Topics: Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Dactinomycin; Fibroblast Growth Factor 2; Glucose; Iron Compounds; Mice; Necrosis; Nerve Growth Factors; Neuroglia; Neurons; Nifedipine; Oxygen; Polymerase Chain Reaction; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Time Factors; Vasodilator Agents | 2002 |
Pharmacological evidence that Ca²+ channels and, to a lesser extent, K+ channels mediate the relaxation of testosterone in the canine basilar artery.
Topics: 4-Aminopyridine; Adenine; Aminoglutethimide; Androgen Receptor Antagonists; Animals; Aromatase Inhibitors; Barium Compounds; Basilar Artery; Calcium Channel Blockers; Calcium Channels; Chlorides; Cycloheximide; Dactinomycin; Dogs; Enzyme Inhibitors; Flutamide; In Vitro Techniques; Male; Nifedipine; Nucleic Acid Synthesis Inhibitors; Oxadiazoles; Potassium Channel Blockers; Potassium Channels; Protein Synthesis Inhibitors; Quinoxalines; Testosterone; Vasodilation; Vasodilator Agents | 2011 |